Upload Avatar (500 x 500)
Qing Chang
qingchang@bjmu.edu.cn
Chinese, English
Beijing
Peking University
Basic Medical Sciences
  • Graduated from the Department of Pathology, Faculty of Medicine, Chinese University of Hong Kong with a PhD degree.
  • Visiting Scholar at the University of Washington, USA in 2016.
  • Established the first domestic molecular typing platform for medulloblastoma based on Nanostring technology.
  • Applied for three national patents.
Tumor molecular pathology
Exosomal miRNA in brain tumor development
Tumor microenvironment in brain tumors
  • Exosomal microRNAs induce tumor-associated macrophages via PPARγ during tumor progression in SHH medulloblastoma, Qing Chang et al., 2022
  • Aggressive Medulloblastoma-Derived Exosomal miRNAs Promote In Vitro Invasion and Migration of Tumor Cells Via Ras/MAPK Pathway, Qing Chang et al., 2020
  • Extracellular microvesicles-derived from microglia treated with unaggregated α-synuclein attenuate mitochondrial fission and toxicity-induced by Parkinsonian toxin MPP, Qing Chang et al., 2019
  • SNCA, a novel diagnostic marker for Group 4 medulloblastomas, can inhibit tumor invasion and induce apoptosis, Qing Chang et al., 2018
  • Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma, Qing Chang et al., 2016
Molecular Typing Biomarkers Mechanism Studies Exosomes Mirna Brain Tumors Tumor Progression Macrophages Astrocytes Pparγ

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.